We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eros | LSE:EROS | London | Ordinary Share | GB00B13JS954 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 235.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
21/3/2014 16:13 | Rivaldo - "Speedsgh, exactly how short-term is your outlook? :o))" Experience to date might suggest that my outlook in this case has not been short term enough seeing as I've been here since 2010. I suppose that I might fall into the category of a stale bull but until now have managed to resist the urge to sell up prior to tasting some of the jam that has been promised for so long. The HBO tie-up + opportunities thrown up by the emergence of VOD + streaming as well as Indian demographics still draws me to the basic investment story. However I certainly have reservations over corporate governance + the way the whole US IPO was bungled was almost the straw that broke the camel's back. Having experienced several false dawns with EROS, I am looking paler than pale through the lack of sunlight! Can't see myself being invested in another 4yrs time + will probably jump ship upon the next decent leg up, whenever that may be. Let's hope that's sooner rather than later. Thanks for your continued input + analysis here. It's been pretty quiet since the move across the pond so it is much appreciated. | speedsgh | |
21/3/2014 15:28 | Not as knowledgeable on this business as many posters, but when a price spikes up like this it brings out sellers, from what I have read here I intend to hold, however I will review things if it was to approach the $14 level. | royaloak | |
21/3/2014 15:17 | Speedsgh, exactly how short-term is your outlook? :o)) The year end is just coming up. Plus there's another new release next week. And then the biggie in April.... IMO the year end trading statement will be extremely good, and enough to drive a further re-rating. But WTFDIK. | rivaldo | |
21/3/2014 15:07 | Is the short-term effect of the recent roadshows starting to wear off? | speedsgh | |
20/3/2014 12:42 | EROS' latest release Shaadi Ke did extremely well - it only cost 20 crore according to this: But it collected 51 crore in India and overseas in the first fortnight alone - and that's without taking into account any pre-sales, TV deals etc and digital income: | rivaldo | |
18/3/2014 15:58 | "Jeffries have upgraded eps for the year that starts end on this month from $1.17 to $1.48 so even on pe terms, not counting the tech appeal of ErosNow, that's gives a target of $26.64 based on 18times." In that case, czar, a UBS target of $18 would be only put EROS on a p.e. of 12 which is very modest - provided,of course, that they wold broadly concur with $1.48. All a bit loose and untidy! | aimingupward2 | |
18/3/2014 15:35 | I have the old UBS note and the price target is $20. Can't find a later one with $40 although I agree this is achievable as the markets wake up to the potential of ErosNow and HBO. | czar | |
17/3/2014 17:30 | It's bizarre. If you google 'UBS Eros target price' you can read the following on several websites: "Investment analysts at UBS AG raised their price target on shares of Eros International plc (NASDAQ:EROS) from $18.00 to $40.00 in a note issued to investors on Thursday," Can it really be so wrongly reported / can it really be true? | aimingupward2 | |
17/3/2014 14:06 | Hmm...I think the original story is incorrect and it should have read $18 judging by this other version. Still, imho it's just possible that EROS will reach $40 at some point if the markets cotton on to the digital potential: Will This Price Target Increase Help Eros International (EROS) Today? BY Shawn Ingram | 03/13/14 - 09:37 AM EDT NEW YORK (TheStreet) -- UBS raised its price target for Eros International (EROS_) to $18 Thursday. Shares of Eros International gained 0.7% to $15.30 in morning trading. The firm maintained its "buy" rating for the movie production company. The increase its due to Eros International's healthy topline growth with solid performance of the film slate and greater contribution from its film catalog." | rivaldo | |
15/3/2014 21:31 | "Eros International plc (NASDAQ:EROS) had its target price increased by UBS AG from $18.00 to $40.00. The firm currently has a buy rating on the stock." I thought EROS was on the NYSE not NASDAQ ! | aimingupward2 | |
15/3/2014 19:23 | Look at how many hits they have on their YouTube channel to get an idea of the potential of ErosNow. Links above... | smurfy2001 | |
15/3/2014 16:25 | Aye does seem a bit rich as this stage , perhaps they know more than us mushrooms regarding the traction of ErosNow ? | loafingchard | |
15/3/2014 12:26 | Rivaldo - can we really believe a $40 price target? I would like to think so, but it means a really heavy p.e multiple, commensurate with tech stocks if they are seeing it that way as well as an entertainment company. Of course they don't say over what time period the target might be reached, but analysts rarely look beyond 2 years and $40 two years from now would be pretty fine and a vast improvement over AIM days. | aimingupward2 | |
15/3/2014 11:27 | Jeffries have upgraded eps for the year that starts end on this month from $1.17 to $1.48 so even on pe terms, not counting the tech appeal of ErosNow, that's gives a target of $26.64 based on 18times. | czar | |
14/3/2014 09:54 | This could be the Netflix of indian movies, that's how l see it. | smurfy2001 | |
14/3/2014 09:45 | Looks like the US sees Eros as a tech play where the cultural demand for Bollywood is being used as the golden key to unlock access to India's 450m middle classes through ErosNow. The valuations being put on tech right now could mean the sky is the limit for Eros. A bit different to AIM. | czar | |
14/3/2014 09:33 | Wow! Let's see what happens today.... | smurfy2001 | |
14/3/2014 09:31 | Hello....$40 from $18 is a bit of an increase :o)) "Eros International plc (NASDAQ:EROS) had its target price increased by UBS AG from $18.00 to $40.00. The firm currently has a buy rating on the stock." | rivaldo | |
13/3/2014 13:58 | Nice - Jefferies have today increased their price target to $18 (around 360p in old money). Note how well the investor meetings have gone.... "Eros International (EROS) Target Lifted to $18 at Jefferies Jefferies analyst Randal Konik reiterated a Buy rating on Eros International Plc (NYSE: EROS) and boosted his price target from $14 to $18 following investor meetings. Konik said, "We hosted Eros mgmt in NYC to discuss the Eros story, which was very well received by investors. We believe Eros is a force to be reckoned with in Indian filmed entertainment and we are encouraged by mgmt's optimistic tone on a number of key strategic initiatives in process. We see a robust growth trajectory ahead as the company executes according to the roadmap we outline below. With enhanced visibility and confidence in the business, we raise our PT to $18." The firm trimmed FY 2014 EPS from $0.97 to $0.80 and raised FY 2015 EPS from $1.17 to $1.48. " | rivaldo | |
13/3/2014 11:04 | "Run your profit as they say". Yes, very true but having run my profits a couple of times previously when the share price perked up when on AIM, each time ended back at square one. So am watching closely this time round in an attempt to make sure that the same doesn't occur again! | speedsgh | |
13/3/2014 10:58 | Run your profit as they say ;-) | smurfy2001 | |
13/3/2014 10:57 | Well if every there was a lesson in patience this was it! | monkeymagic3 | |
13/3/2014 09:14 | EROS' latest movie out this month - Shaadi Ke - has been fine at the Indian box office, but has been a great success globally. And it's overseas where the largest margins are achieved... Shaadi Ke Side Effects Makes 2 Million plus Overseas in 5 Days! Mumbai: Balaji Motion Pictures and Pritish Nandy Communications film 'Shaadi Ke Side Effects', which stars Farhan Akhtar and Vidya Balan, has created ripples not only at the Indian box office but also in the overseas market. As per the sources, "Shaadi Ke Side Effects has really done well in the overseas market and after crossing 2 million in just 5 days, it is predicted that the film will make much more in the coming few days!" The trade source also added that the film has done better than Farhan Akhtar's last film 'Bhaag Milkha Bhaag', the biopic on Indian athlete Milkha Singh, which was anyways a major blockbuster. Alpana Mishra (CEO, Balaji) said, We were very buoyant on the overseas performance of the film from word go as the content would resonate with the audience in North America etc. These numbers have more than justified our conviction! And its performing across the World not just in select pockets. We are extremely thrilled and are Overseas Partners Eros are equally delighted with this result. Looking for much more over the coming weekend and days ahead etc" | rivaldo | |
12/3/2014 22:46 | Finished at the day's high - and possibly (just!) a new high on the NYSE. Very nice, but hopefully just the start. | rivaldo | |
12/3/2014 21:51 | Well this is one stock that actually went up in my portfolio today! :) | smurfy2001 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions